脑源性神经营养因子基因转染骨髓间充质干细胞在受损耳蜗内的生存和分化

A Preliminary Study of Brain-Derived Neurotrophic Factor Gene Transfected Bone-Marrow Mesenchymal Stem Cells Transplartafion Damaged Cochlea

刘谦虚;贺湘波;陈观贵;谢鼎华;谭志强;

1:中南大学耳科研究所

2:湘雅二医院耳鼻咽喉头颈外科

3:暨南大学医学院第三附属医院(珠海市人民医院)耳鼻咽喉头颈外科

4:广州医学院第二附属医院耳鼻咽喉科

摘要
目的探讨脑源性神经营养因子(brain-derived neurotrophic factor gene,BDNF)基因转染的骨髓间充质干细胞(bone-marrow mesenchymal stem cells,BMSC)在受损耳蜗内的生存和分化情况。方法将转染了BDNF基因并在体外诱导分化的BMSC(BDNF-BMSC)标记后,通过鼓阶注射植入阿米卡星致聋的豚鼠耳蜗内(BDNF-BMSC组,18只),并设注射未诱导分化的BMSC的豚鼠为对照组(BMSC组,18只)。在注射后1、2、4w取耳蜗组织石蜡切片,HE染色和荧光染色观察注射细胞的分布;神经元特异性烯醇化酶(neuron-specificenolase,NSE)、胶质纤维酸性蛋白(glial fibrillary acid protien,GFAP)抗体免疫组化染色观察注射细胞在耳蜗内的分化。结果 BDNF-BMSC和BMSC在耳蜗内均能成活并分布到一定的区域,鼓阶和前庭阶较多,中阶和蜗轴较少。NSE和GFAP免疫化学可见BDNF-BMSC部分细胞阳性染色,而BMSC阳性细胞较少。BDNF-BMSC在1、2w时平均光密度(AOD)值较高,在4w时显著下降(P<0.05);在各时间点,BDNF-BMSC组AOD值均显著高于BMSC组(P<0.01)。结论诱导分化前后的BMSC耳蜗移植后均能成活并分布到一定的区域,在耳蜗内BDNF-BMSC分化能力明显强于BMSC,但随时间延长分化能力下降。
关键词
脑源性神经营养因子基因;骨髓间充质干细胞;耳蜗
基金项目(Foundation):
“湖南省十一五期间贫困残疾儿童人工耳蜗植入援助计划”专项资助课题
作者
刘谦虚;贺湘波;陈观贵;谢鼎华;谭志强;
参考文献

1Okano T,Nakagawa T,Kita T,et al.Cell-gene delivery of brain-derived neurotrophic factor to the mouse inner ear[J].Mol Ther,2006,14:866.

2刘谦虚,谢鼎华,陈观贵.脑源性神经营养因子基因转染骨髓间充质干细胞体外诱导分化为神经样细胞初步观察[J].听力学及言语疾病杂志,2009,17:252.

3Shepherd RK,Coco A,Epp SB.Neurotrophins and electrical sti m-ulationfor protectionandrepair of spiral ganglion neuronsfollowing sensorineural hearingloss[J].Hear Res,2008,242:100.

4Kronenwett R,Haas R.Differentiation potential of stem cells frombone marrow[J].Med Klin(Munich),2006,101(Suppl1):182.

5Mahmood A,Lu D,Wang L,et al.Intracerebral transplanta-tion of marrowstromal cells cultured with neurotrophic factors promotes functional recovery in adult rats subjected to yrau-matic brain injury[J].Journal of Neurotrauma,2002,19:1609.

6康德智,王灯亮,林建华,等.骨髓间质干细胞和脑源性神经营养因子联合应用促进兔脊髓外伤性截瘫的修复[J].中国临床解剖学杂志,2007,25:60.

7Ito J,Koji ma K,Kawaguchi S.Survival of neural stemcellsin the cochlea[J].Acta Otolaryngol,2001,121:140.

8Hildebrand MS,Dahl HH,Hardman J,et al.Survival of par-tially differentiated mouse embryonic stem cells in the scala media of the guinea pig cochlea[J].Assoc Res Otolaryngol,2005,6:341.

9Wang JS,Shum TD,Galipeau J,et al.Marrow mesenchymal stemcells for cellular cardiomyoplasty:feasibility and potential clinical advantages[J].Thorac Cardiovasc Surg,2000,120:999.

10Sharif S,Nakagawa T,Ohno T,et al.The potential use of bone marrowstromal cells for cochlear cell therapy[J].Neu-roreport,2007,18:351.

11Hu Z,Wei D,Johansson CB,et al.Survival and neural dif-ferentiation of adult neural stem cells transplanted into the mature inner ear[J].Exp Cell Res,2005,302:40.

12Matsuoka AJ,Kondo T,Miyamoto RT,et al.Enhanced survival of bone marrow-derived pluripotent stemcells in an ani mal model of auditory neuropathy[J].Laryngoscope,2007,117:1629.

13Naito Y,Nakamura T,Nakagawa T,et al.Transplantation of bone marrow stromal cells into the cochlea of chinchillas[J].Neuroreport,2004,15:1.

14Hildebrand MS,Dahl HH,Hardman J,et al.Survival of partially differentiated mouse embryonic stemcellsin the sca-la media of the guinea pig cochlea[J].Assoc Res Otolaryn-gol,2005,6:341.